Skip to content

Comparison of the effects of thyroid treatment on ovarian function and pregnancy outcomes in female patients with differentiated thyroid cancer: a prospective clinical cohort study

Comparison of the effects of thyroid treatment on ovarian function and pregnancy outcomes in female patients with differentiated thyroid cancer: a prospective clinical cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400088517
Enrollment
Unknown
Registered
2024-08-20
Start date
2024-08-20
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Differentiated thyroid cancer

Interventions

Control:Resection of one lobe and isthmus of the thyroid gland
Experimental Group 1:Total thyroidectomy
Experimental Group 2:Total thyroidectomy and RAIT

Sponsors

Zhejiang Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1) Age 20-45 years old; 2) Thyroid B-ultrasound + surgical pathology is clearly defined as premenopausal women with differentiated thyroid cancer (pillary thyroid cancer or follicular thyroid cancer); 3) TNM stage is in stage I (T1-3, N0 or N1, M0); 4) Thyroid tumor resection treatment: thyroid side lobe + isthmus resection, total thyroidectomy, total thyroidectomy + RAIT.

Exclusion criteria

Exclusion criteria: 1) Patients with malignant tumors or low undifferentiated thyroid cancer in other parts; 2) abnormal liver and kidney function; 3) TNM stage II and above; 4) history of ovarian surgery, hysterectomy, pelvic surgery or radiation treatment; 5) in pregnancy; 6) with the following uterus Abnormalities, such as uterine malformations (unigonal uterus, double uterus); untreated mediastinal uterus, submucosal uterine fibroids, multiple endometrial polyps, or severe uterine adhesions. 7) Patients diagnosed with polycystic ovary syndrome by Rotterdam standards; 8) Patients with ovarian insufficiency; 9) Patients have infectious factors, immune diseases and metabolic diseases that may affect the outcome of pregnancy; 10) There are contraindications for pregnancy or diseases that have a clear impact on pregnancy.

Design outcomes

Primary

MeasureTime frame
Anti-Mueller tube hormone;Sex hormones;Number of sinus follicles;

Secondary

MeasureTime frame
Thyroid function;Physical examination;

Countries

China

Contacts

Public ContactGe Minghua

Zhejiang Provincial People's Hospital

gemingh@163.com+86 136 0581 3782

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026